News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,206 Results
Type
Article (8055)
Company Profile (140)
Press Release (477010)
Multimedia
Podcasts (5)
Webinars (6)
Section
Business (166792)
Career Advice (305)
Deals (25748)
Drug Delivery (7)
Drug Development (52920)
Employer Resources (14)
FDA (9764)
Job Trends (8579)
News (238262)
Policy (17912)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (489)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33174)
ALS (105)
Alzheimer's disease (981)
Antibody-drug conjugate (ADC) (272)
Approvals (10394)
Artificial intelligence (323)
ASCO (159)
Autoimmune disease (208)
Automation (28)
Bankruptcy (263)
Best Places to Work (6968)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (112)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (29)
Breast cancer (515)
Cancer (3686)
Cardiovascular disease (221)
Career advice (246)
Career pathing (1)
CAR-T (175)
CDMO (7)
Celiac Disease (1)
Cell therapy (479)
Cervical cancer (34)
Clinical research (47952)
Collaboration (1254)
Commercialization (3)
Compensation (1477)
Complete response letters (34)
COVID-19 (765)
CRISPR (64)
C-suite (762)
Cystic fibrosis (85)
Data (5722)
Denatured (4)
Depression (102)
Dermatology (63)
Diabetes (345)
Diagnostics (4194)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (156)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73741)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87782)
Executive appointments (708)
FDA (12431)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (930)
Gene editing (127)
Generative AI (9)
Gene therapy (329)
GLP-1 (295)
Government (956)
Grass and pollen (2)
Guidances (281)
Healthcare (9346)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (99)
Immuno-oncology (59)
Indications (157)
Infectious disease (953)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (258)
Interviews (42)
IPO (12390)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (61)
Legal (5209)
Licensing (11)
Liver cancer (45)
Longevity (18)
Lung cancer (514)
Lymphoma (254)
Machine learning (27)
Management (3)
Manufacturing (540)
Marketing (8)
MASH (118)
Medical device (8665)
Medtech (8813)
Mergers & acquisitions (14401)
Metabolic disorders (711)
mRNA (59)
Multiple sclerosis (103)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (40)
Neuroscience (1838)
NextGen: Class of 2026 (3156)
Non-profit (852)
Obesity (226)
Opinion (11)
Ovarian cancer (160)
Pain (173)
Pancreatic cancer (201)
Parkinson's disease (201)
Partnered (12)
Patents (482)
Patient recruitment (514)
Peanut (31)
People (41296)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15498)
Phase 2 (21419)
Phase 3 (14439)
Pipeline (7459)
Policy (18)
Postmarket research (1572)
Preclinical (6542)
Press Release (34)
Prostate cancer (191)
Psychedelics (7)
Radiopharmaceuticals (191)
Rare diseases (580)
Real estate (3024)
Recruiting (6)
Regulatory (14884)
Reports (21)
Research institute (583)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (101)
Series A (158)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
The Weekly (1)
Vaccines (331)
Venture capital (17)
Weight loss (73)
Women's health (82)
Date
Today (118)
Last 7 days (315)
Last 30 days (1602)
Last 365 days (19044)
2026 (12716)
2025 (19260)
2024 (23007)
2023 (26544)
2022 (34595)
2021 (37182)
2020 (33482)
2019 (23266)
2018 (17480)
2017 (18773)
2016 (17923)
2015 (24263)
2014 (21685)
2013 (18135)
2012 (20221)
2011 (20441)
2010 (20333)
Location
Africa (228)
Alabama (74)
Alaska (2)
Arizona (306)
Arkansas (11)
Asia (17930)
Australia (2103)
California (12082)
Canada (3177)
China (531)
Colorado (488)
Connecticut (414)
Delaware (208)
Europe (24692)
Florida (1811)
Georgia (386)
Hawaii (3)
Idaho (46)
Illinois (708)
India (51)
Indiana (317)
Iowa (15)
Japan (412)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1208)
Massachusetts (7919)
Michigan (308)
Minnesota (564)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (118)
New Hampshire (60)
New Jersey (2642)
New Mexico (12)
New York (2837)
North Carolina (1294)
North Dakota (4)
Northern California (6067)
Ohio (282)
Oklahoma (14)
Oregon (16)
Pennsylvania (2269)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5015)
Tennessee (122)
Texas (1965)
United States (39213)
Utah (363)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (935)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,206 Results for "gtx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
April 24, 2026
·
8 min read
Press Releases
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
March 19, 2026
·
8 min read
Press Releases
Grace Therapeutics Granted Sixth U.S. Patent Covering I.V. Dosing Regimen for GTx-104
September 18, 2025
·
8 min read
Press Releases
Ultragenyx Announces First Patient Dosed in Aurora Study Evaluating GTX-102 in Additional Angelman Syndrome Genotypes and Age Groups
October 31, 2025
·
8 min read
Press Releases
Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome
June 27, 2025
·
7 min read
Business
Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX
Halberd Corporation is thrilled to declare the formalization of a profitable revenue-sharing accord with Athena GTX, Inc., of Johnston, Iowa,. Athena GTX is a private enterprise specializing in providing medical care solutions tailored for first responders in both civilian and government sectors.
January 9, 2024
·
5 min read
Press Releases
Grace Therapeutics Announces U.S. Food and Drug Administration Acceptance for Review of New Drug Application for GTx-104
August 28, 2025
·
9 min read
Press Releases
Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome
July 31, 2025
·
7 min read
Drug Development
Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102
Ultragenyx Pharmaceutical Inc. announced new data from the Phase 1/2 study of GTX-102 for the treatment of Angelman syndrome.
April 15, 2024
·
12 min read
Press Releases
Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104
June 25, 2025
·
9 min read
1 of 48,521
Next
